Manuela Buxo

Executive Vice President, Specialty Care · Sanofi

Pharmaceuticals

Manuela Buxo is Sanofi’s executive vice president for Specialty Care, following leadership of its immunology alliance, European specialty-care operations and consumer-health strategy.

Last reviewed: Nov 15, 2026

Manuela Buxo

Executive Summary

Manuela Buxo is Sanofi’s executive vice president for Specialty Care, following leadership of its immunology alliance, European specialty-care operations and consumer-health strategy.

Career Highlights

  • Spent 14 years at Bayer in global brand and business-unit management.
  • Joined Sanofi in 2014 and later led Specialty Care in Europe.
  • Became executive vice president for Specialty Care in March 2026.

Professional Journey

Buxo spent 14 years at Bayer, working in global brand and business-unit management before joining Sanofi in 2014. Her international healthcare career has included assignments in Germany, the Netherlands, France, Switzerland, the United States and Mexico.

She entered Sanofi as vice president, Global Categories & Innovation, in Consumer Health. In 2017 she became senior vice president, Global Strategic Marketing, before taking responsibility for the European region of the Specialty Care business in 2020.

That regional portfolio encompassed immunology, neurology, oncology, rare diseases and rare blood disorders. From 2023, Buxo served as global head of the Immunology Alliance, overseeing Dupixent and Kevzara.

She became executive vice president and head of Specialty Care on March 1, 2026. Her team delivers medicines across immunology, neurology, oncology and rare disease, extending her earlier therapeutic-area and regional experience into leadership of the global business unit.

Education

Buxo is a graduate of HHL Leipzig Graduate School of Management and holds an undergraduate degree from Friedrich Schiller University Jena.